Delayed anastomotic leakage following sphincter-preserving surgery for rectal cancer.
OBJECTIVE
The aim of the present study was to investigate the characteristics of patients who developed delayed anastomotic leakage (DAL) following sphincter-preserving surgery for rectal cancer. We evaluated the following factors: (1) the incidence of DAL, (2) the clinical features of patients who developed DAL, (3) the risk factors for DAL, and (4) treatment outcomes.


METHODS
We reviewed the case histories of 1,838 rectal cancer patients who had undergone curative resection with sphincter preservation and without protective stoma formation between January 2000 and December 2006. DAL was defined as the development of a pelvic abscess or fistula around the anastomosis more than 3 weeks post-surgery in patients without tumor recurrence who had resumed a normal diet and defecation.


RESULTS
In 1.3% (24/1,838) of the patients, DAL developed on median postoperative day 99 (range 22-2,069). Pelvic abscess (50%) and anastomotic-vaginal fistula (41.7%) were the most common causes of DAL. Independent risk factors for the development of DAL were: (1) female gender (hazard ratio 3.03; 95% CI 1.06-8.8), (2) low-level anastomosis (< or = 4 cm from the anal verge) (hazard ratio 5.76; 95% CI 1.37-22.39), and (3) preoperative chemoradiation therapy (hazard ratio 4.56; 95% CI 1.4-14.92). Stoma formation was performed in all of the 24 patients. The 3-year stoma-retention rate in patients with DAL was significantly higher than in patients with early anastomotic leakage (72.2% vs 17.5%, P < 0.001).


CONCLUSIONS
DAL following sphincter-preserving surgery for rectal cancer occurred relatively frequently in our sample and was associated with female gender, a low level of anastomosis, and preoperative radiotherapy. DAL patients required long-term or permanent stomas.
Shin
Ui Sup
US
Department of Colonic and Rectal Surgery, Asan Medical Center, University of Ulsan College of Medicine, Songpa-gu, Seoul, Korea.
Kim
Chan Wook
CW
Yu
Chang Sik
CS
Kim
Jin Cheon
JC
D001003:Anal Canal / Q000473:pathology / Q000601:surgery*; D000714:Anastomosis, Surgical / Q000009:adverse effects*; D006801:Humans; D053208:Kaplan-Meier Estimate; D015999:Multivariate Analysis; D020360:Neoadjuvant Therapy; D012004:Rectal Neoplasms / Q000473:pathology / Q000532:radiotherapy / Q000601:surgery*; D012307:Risk Factors; D016896:Treatment Outcome
Chirurg. 2000 Nov;71(11):1365-9
11132323
Dis Colon Rectum. 1983 Apr;26(4):231-5
6839891
Dis Colon Rectum. 2004 Dec;47(12):2184-94
15657672
Ann Surg. 1999 Oct;230(4):544-52; discussion 552-4
10522724
Ann Surg. 2007 Aug;246(2):207-14
17667498
Br J Surg. 2001 Mar;88(3):400-4
11260107
Dis Colon Rectum. 1981 May-Jun;24(4):236-42
7016480
Dis Colon Rectum. 1981 Sep;24(6):437-44
7273981
Dis Colon Rectum. 2008 Jun;51(6):902-8
18408971
Br J Surg. 1998 Mar;85(3):355-8
9529492
J Am Coll Surg. 1997 Aug;185(2):105-13
9249076
Gynecol Oncol. 2004 Aug;94(2):277-82
15297162
Dis Colon Rectum. 1992 Oct;35(10):938-43
1395980
Langenbecks Arch Surg. 2002 Jun;387(2):94-100
12111262
Br J Surg. 2003 Oct;90(10):1261-6
14515297
Colorectal Dis. 2004 Nov;6(6):462-9
15521937
Radiat Med. 1999 Mar-Apr;17(2):181-7
10399789
Colorectal Dis. 2005 Jan;7(1):51-7
15606585
Br J Surg. 2005 Sep;92(9):1137-42
15997447
Am J Surg. 2000 Feb;179(2):92-6
10773140
Ann Surg. 2004 Aug;240(2):255-9
15273549
Br J Surg. 1996 Jan;83(1):60-2
8653367
Surgery. 2005 Mar;137(3):329-36
15746788
Colorectal Dis. 2001 Mar;3(2):135-7
12791007